menu
    • menu

    Company profile for Tempus

    NEW Drugs in Dev: 5
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Tempus is making precision medicine a reality through the power and promise of data and artificial intelligence. With the world’s largest library of clinical and molecular data, and an operating system to make that data accessible and useful, we enable physicians to make real-time, data-driven decisions to deliver personalized patient care, and in parallel, facilitate discovery, development, and delivery of optimized therap...
    Tempus is making precision medicine a reality through the power and promise of data and artificial intelligence. With the world’s largest library of clinical and molecular data, and an operating system to make that data accessible and useful, we enable physicians to make real-time, data-driven decisions to deliver personalized patient care, and in parallel, facilitate discovery, development, and delivery of optimized therapeutic options for patients through distinctive solution sets. With the right data, we can accelerate cancer research. We can usher in an era of true precision medicine and revolutionize.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TempusUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    600 W Chicago Ave. Ste 510, Chicago, IL 60654
    Telephone
    Telephone
    833.514.4187
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tempus.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tempuslabs/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BMS Partners With Tempus To Enhance Clinical Success With AI
    BMS Partners With Tempus To Enhance Clinical Success With AI

    15 May 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7429564

    FIRSTWORD PHARMA
    15 May 2026
    Share Share
    Tempus, USC Team Up to Advance AI-Driven Precision Medicine
    Tempus, USC Team Up to Advance AI-Driven Precision Medicine

    23 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260423718135/en/Tempus-and-USC-Announce-Strategic-Collaboration-to-Accelerate-AI-Driven-Precision-Medicine

    BUSINESSWIRE
    23 Apr 2026
    Share Share
    Tempus to Report Q1 2026 Financial Results on May 5
    Tempus to Report Q1 2026 Financial Results on May 5

    21 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260421566236/en/Tempus-to-Report-First-Quarter-2026-Financial-Results-on-May-5

    BUSINESSWIRE
    21 Apr 2026
    Share Share
    Tempus, Predicta Expand Access to Genome Sequencing
    Tempus, Predicta Expand Access to Genome Sequencing

    15 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260415412276/en/Tempus-and-Predicta-Biosciences-Announce-Collaboration-to-Expand-Life-Sciences-Access-to-Ultrasensitive-Whole-Genome-Sequencing-Assay-for-Hematologic-Malignancies-and-MRD-Monitoring

    BUSINESSWIRE
    15 Apr 2026
    Share Share
    Tempus Announces 31 Abstracts for Presentation at AACR 2026
    Tempus Announces 31 Abstracts for Presentation at AACR 2026

    14 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260414517979/en/Tempus-Announces-31-Abstracts-for-Presentation-at-the-American-Association-for-Cancer-Research-Annual-Meeting-2026

    BUSINESSWIRE
    14 Apr 2026
    Share Share
    Genialis Supermodel Predicts Her2 Therapy Response In Patients
    Genialis Supermodel Predicts Her2 Therapy Response In Patients

    13 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-13/genialis-supermodel-predicts-patient-response-to-her2-targeted-therapy-enhertu

    PHARMIWEB
    13 Apr 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search